Year: Fund Million Trimas — Why a Trim Made Sense Now
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Find out which credit card offers the most points for your purchases. Make your spending work harder for you with the right card.
24,145 articlesA mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Investors often wonder if AMD stock now is the right move. This guide analyzes the catalysts, risks, and practical st...
Explore how Uri Levine’s problem-first approach fuels startup success, from Waze’s ascent to the future of autonomous...
The National Association of Realtors unveiled a new consumer campaign to showcase Realtor services and the value they...
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...
A major portfolio pivot is unfolding as 13F data reveals a famous hedge fund manager changing course. Learn why billi...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
Prediction-market odds now place bitcoin's year-end odds reaching 10%. This article breaks down what that means for y...
As markets shift in early 2026, dividend-growth stocks offer retirees predictable income. Here are four blue chips wi...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...